• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

MLb-LDLr:一种预测错义变异致病性的机器学习模型。

MLb-LDLr: A Machine Learning Model for Predicting the Pathogenicity of Missense Variants.

作者信息

Larrea-Sebal Asier, Benito-Vicente Asier, Fernandez-Higuero José A, Jebari-Benslaiman Shifa, Galicia-Garcia Unai, Uribe Kepa B, Cenarro Ana, Ostolaza Helena, Civeira Fernando, Arrasate Sonia, González-Díaz Humberto, Martín César

机构信息

Fundación Biofísica Bizkaia, Leioa, Spain.

Instituto Biofisika (UPV/EHU, CSIC), University of the Basque Country, Leioa, Spain.

出版信息

JACC Basic Transl Sci. 2021 Nov 22;6(11):815-827. doi: 10.1016/j.jacbts.2021.08.009. eCollection 2021 Nov.

DOI:10.1016/j.jacbts.2021.08.009
PMID:34869944
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8617597/
Abstract

Untreated familial hypercholesterolemia (FH) leads to atherosclerosis and early cardiovascular disease. Mutations in the low-density lipoprotein receptor () gene constitute the major cause of FH, and the high number of mutations already described in the makes necessary cascade screening or in vitro functional characterization to provide a definitive diagnosis. Implementation of high-predicting capacity software constitutes a valuable approach for assessing pathogenicity of variants to help in the early diagnosis and management of FH disease. This work provides a reliable machine learning model to accurately predict the pathogenicity of missense variants with specificity of 92.5% and sensitivity of 91.6%.

摘要

未经治疗的家族性高胆固醇血症(FH)会导致动脉粥样硬化和早期心血管疾病。低密度脂蛋白受体()基因突变是FH的主要病因,该基因中已描述的大量突变使得有必要进行级联筛查或体外功能表征以做出明确诊断。实施具有高预测能力的软件是评估基因变异致病性的一种有价值的方法,有助于FH疾病的早期诊断和管理。这项工作提供了一个可靠的机器学习模型,以92.5%的特异性和91.6%的敏感性准确预测基因错义变异的致病性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6cf2/8617597/6c4e5a9c0483/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6cf2/8617597/f568e8523b86/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6cf2/8617597/805961ac86d0/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6cf2/8617597/27d1b3f2de67/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6cf2/8617597/ef2a28361089/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6cf2/8617597/b0195fe34077/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6cf2/8617597/6c4e5a9c0483/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6cf2/8617597/f568e8523b86/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6cf2/8617597/805961ac86d0/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6cf2/8617597/27d1b3f2de67/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6cf2/8617597/ef2a28361089/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6cf2/8617597/b0195fe34077/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6cf2/8617597/6c4e5a9c0483/gr5.jpg

相似文献

1
MLb-LDLr: A Machine Learning Model for Predicting the Pathogenicity of Missense Variants.MLb-LDLr:一种预测错义变异致病性的机器学习模型。
JACC Basic Transl Sci. 2021 Nov 22;6(11):815-827. doi: 10.1016/j.jacbts.2021.08.009. eCollection 2021 Nov.
2
Systematic prediction of familial hypercholesterolemia caused by low-density lipoprotein receptor missense mutations.系统预测低密度脂蛋白受体错义突变引起的家族性高胆固醇血症。
Atherosclerosis. 2019 Feb;281:1-8. doi: 10.1016/j.atherosclerosis.2018.12.003. Epub 2018 Dec 15.
3
Cellular and functional evaluation of LDLR missense variants reported in hypercholesterolemic patients demonstrates their hypomorphic impacts on trafficking and LDL internalization.对高胆固醇血症患者中报告的低密度脂蛋白受体(LDLR)错义变体进行的细胞和功能评估表明,它们对转运和LDL内化具有低表达影响。
Front Cell Dev Biol. 2024 Jul 24;12:1412236. doi: 10.3389/fcell.2024.1412236. eCollection 2024.
4
Novel LDLR variants in patients with familial hypercholesterolemia: in silico analysis as a tool to predict pathogenic variants in children and their families.家族性高胆固醇血症患者中的新型低密度脂蛋白受体(LDLR)变异:计算机模拟分析作为预测儿童及其家族中致病变异的工具。
Ann Hum Genet. 2013 Sep;77(5):426-34. doi: 10.1111/ahg.12032. Epub 2013 Jul 2.
5
OptiMo-LDLr: An Integrated In Silico Model with Enhanced Predictive Power for LDL Receptor Variants, Unraveling Hot Spot Pathogenic Residues.OptiMo-LDLr:一种具有增强预测能力的 LDL 受体变异体的集成计算模型,揭示热点致病残基。
Adv Sci (Weinh). 2024 Apr;11(13):e2305177. doi: 10.1002/advs.202305177. Epub 2024 Jan 23.
6
Clinical characterization and mutation spectrum of German patients with familial hypercholesterolemia.德国家族性高胆固醇血症患者的临床特征及突变谱。
Atherosclerosis. 2016 Oct;253:88-93. doi: 10.1016/j.atherosclerosis.2016.08.037. Epub 2016 Aug 26.
7
DIAgnosis and Management Of familial hypercholesterolemia in a Nationwide Design (DIAMOND-FH): Prevalence in Switzerland, clinical characteristics and the diagnostic value of clinical scores.在全国范围内设计(DIAMOND-FH)中诊断和管理家族性高胆固醇血症:瑞士的流行情况、临床特征和临床评分的诊断价值。
Atherosclerosis. 2018 Oct;277:282-288. doi: 10.1016/j.atherosclerosis.2018.08.009.
8
Two Novel Disease-Causing Mutations in the LDLR of Familial Hypercholesterolemia.家族性高胆固醇血症低密度脂蛋白受体中的两个新型致病突变
Front Genet. 2021 Dec 14;12:762587. doi: 10.3389/fgene.2021.762587. eCollection 2021.
9
Spectrum of low-density lipoprotein receptor (LDLR) mutations in a cohort of Sri Lankan patients with familial hypercholesterolemia - a preliminary report.斯里兰卡家族性高胆固醇血症患者中低密度脂蛋白受体 (LDLR) 突变谱 - 初步报告。
Lipids Health Dis. 2018 May 2;17(1):100. doi: 10.1186/s12944-018-0763-z.
10
Validation of LDLr Activity as a Tool to Improve Genetic Diagnosis of Familial Hypercholesterolemia: A Retrospective on Functional Characterization of LDLr Variants.验证 LDLr 活性作为改善家族性高胆固醇血症遗传诊断的工具:对 LDLr 变异体功能特征的回顾性研究。
Int J Mol Sci. 2018 Jun 5;19(6):1676. doi: 10.3390/ijms19061676.

引用本文的文献

1
Large-Scale Functional Characterization of Low-Density Lipoprotein Receptor Gene Variants Improves Risk Assessment in Cardiovascular Disease.低密度脂蛋白受体基因变异的大规模功能表征改善了心血管疾病的风险评估。
JACC Basic Transl Sci. 2025 Feb;10(2):170-183. doi: 10.1016/j.jacbts.2024.10.006. Epub 2024 Dec 11.
2
Familial Hypercholesterolemia: From Clinical Suspicion to Novel Treatments.家族性高胆固醇血症:从临床怀疑到新型治疗
Rev Cardiovasc Med. 2023 Nov 9;24(11):311. doi: 10.31083/j.rcm2411311. eCollection 2023 Nov.
3
MLe-KCNQ2: An Artificial Intelligence Model for the Prognosis of Missense Gene Variants.

本文引用的文献

1
Diagnostic yield of sequencing familial hypercholesterolemia genes in individuals with primary hypercholesterolemia.家族性高胆固醇血症基因测序在原发性高胆固醇血症患者中的诊断收益。
Rev Esp Cardiol (Engl Ed). 2021 Aug;74(8):664-673. doi: 10.1016/j.rec.2020.06.003. Epub 2020 Jul 11.
2
Mutation type classification and pathogenicity assignment of sixteen missense variants located in the EGF-precursor homology domain of the LDLR.载脂蛋白 B 100 基因第 3500 位碱基缺失突变致家族性高胆固醇血症家系的基因诊断
Sci Rep. 2020 Feb 3;10(1):1727. doi: 10.1038/s41598-020-58734-9.
3
Systematic prediction of familial hypercholesterolemia caused by low-density lipoprotein receptor missense mutations.
MLe-KCNQ2:一种用于预测错义基因变异预后的人工智能模型。
Int J Mol Sci. 2024 Mar 2;25(5):2910. doi: 10.3390/ijms25052910.
4
Effect of mixed meal replacement of soybean meal on growth performance, nutrient apparent digestibility, and gut microbiota of finishing pigs.豆粕混合替代物对育肥猪生长性能、养分表观消化率及肠道微生物群的影响。
Front Vet Sci. 2024 Feb 1;11:1321486. doi: 10.3389/fvets.2024.1321486. eCollection 2024.
5
OptiMo-LDLr: An Integrated In Silico Model with Enhanced Predictive Power for LDL Receptor Variants, Unraveling Hot Spot Pathogenic Residues.OptiMo-LDLr:一种具有增强预测能力的 LDL 受体变异体的集成计算模型,揭示热点致病残基。
Adv Sci (Weinh). 2024 Apr;11(13):e2305177. doi: 10.1002/advs.202305177. Epub 2024 Jan 23.
6
Predictive Modeling and Structure Analysis of Genetic Variants in Familial Hypercholesterolemia: Implications for Diagnosis and Protein Interaction Studies.家族性高胆固醇血症中遗传变异的预测建模和结构分析:对诊断和蛋白质相互作用研究的影响。
Curr Atheroscler Rep. 2023 Nov;25(11):839-859. doi: 10.1007/s11883-023-01154-7. Epub 2023 Oct 17.
7
Applications of machine learning in familial hypercholesterolemia.机器学习在家族性高胆固醇血症中的应用。
Front Cardiovasc Med. 2023 Sep 26;10:1237258. doi: 10.3389/fcvm.2023.1237258. eCollection 2023.
8
Novel Tools for Comprehensive Functional Analysis of LDLR (Low-Density Lipoprotein Receptor) Variants.用于全面功能分析 LDLR(低密度脂蛋白受体)变异体的新工具。
Int J Mol Sci. 2023 Jul 14;24(14):11435. doi: 10.3390/ijms241411435.
9
Genetic Heterogeneity of Familial Hypercholesterolemia: Repercussions for Molecular Diagnosis.家族性高胆固醇血症的遗传异质性:对分子诊断的影响。
Int J Mol Sci. 2023 Feb 6;24(4):3224. doi: 10.3390/ijms24043224.
10
Continuous Bayesian variant interpretation accounts for incomplete penetrance among Mendelian cardiac channelopathies.连续贝叶斯变异解释考虑了孟德尔心脏通道病中的不完全外显率。
Genet Med. 2023 Mar;25(3):100355. doi: 10.1016/j.gim.2022.12.002. Epub 2022 Dec 7.
系统预测低密度脂蛋白受体错义突变引起的家族性高胆固醇血症。
Atherosclerosis. 2019 Feb;281:1-8. doi: 10.1016/j.atherosclerosis.2018.12.003. Epub 2018 Dec 15.
4
Familial Hypercholesterolemia: The Most Frequent Cholesterol Metabolism Disorder Caused Disease.家族性高胆固醇血症:最常见的胆固醇代谢紊乱引起的疾病。
Int J Mol Sci. 2018 Nov 1;19(11):3426. doi: 10.3390/ijms19113426.
5
CADD: predicting the deleteriousness of variants throughout the human genome.CADD:预测整个人类基因组中变异的有害性。
Nucleic Acids Res. 2019 Jan 8;47(D1):D886-D894. doi: 10.1093/nar/gky1016.
6
Deep learning in biomedicine.深度学习在生物医学中的应用。
Nat Biotechnol. 2018 Oct;36(9):829-838. doi: 10.1038/nbt.4233. Epub 2018 Sep 6.
7
Validation of LDLr Activity as a Tool to Improve Genetic Diagnosis of Familial Hypercholesterolemia: A Retrospective on Functional Characterization of LDLr Variants.验证 LDLr 活性作为改善家族性高胆固醇血症遗传诊断的工具:对 LDLr 变异体功能特征的回顾性研究。
Int J Mol Sci. 2018 Jun 5;19(6):1676. doi: 10.3390/ijms19061676.
8
Analysis of publicly available LDLR, APOB, and PCSK9 variants associated with familial hypercholesterolemia: application of ACMG guidelines and implications for familial hypercholesterolemia diagnosis.分析与家族性高胆固醇血症相关的 LDLR、APOB 和 PCSK9 常见变异:ACMG 指南的应用及其对家族性高胆固醇血症诊断的影响。
Genet Med. 2018 Jun;20(6):591-598. doi: 10.1038/gim.2017.151. Epub 2017 Oct 26.
9
ClinVar: improving access to variant interpretations and supporting evidence.ClinVar:改善变异解读和支持证据的获取。
Nucleic Acids Res. 2018 Jan 4;46(D1):D1062-D1067. doi: 10.1093/nar/gkx1153.
10
Cascade Screening for Familial Hypercholesterolemia and the Use of Genetic Testing.家族性高胆固醇血症的级联筛查与基因检测的应用
JAMA. 2017 Jul 25;318(4):381-382. doi: 10.1001/jama.2017.8543.